Navigation Links
Taboo Health Concern Facing Young Women On Birth Control
Date:9/18/2012

NEW YORK, Sept. 18, 2012 /PRNewswire/ -- According to the Guttmacher Institute, over ten million women in the US use oral contraceptives. Although birth control pills are an effective way to prevent pregnancy, keep acne at bay, and treat menstrual pain or irregularity, there may be some health concerns that are undisclosed to patients. A recent study suggests that oral contraceptive use can lead to increased pain during intercourse, with decreased libido and spontaneous arousability as well as diminished frequency of sexual intercourse and orgasm in young women.

(Logo:  http://photos.prnewswire.com/prnh/20120717/NY41829 )

Several recent studies indicate that the use of oral contraceptives is associated with a substantially increased risk of developing vestibulodynia. Additionally, oral contraceptives are known to cause perturbations in serum estradiol, free testosterone levels, and hormonal receptors, as well as alter the morphological pattern of the vulvar vestibular mucosa. Some leading researchers are therefore hypothesizing that these changes may induce atrophic changes in the mucosa of the vulvar vestibule, leading to discomfort and pain with sex; similar to menopausal women.

Women suffering from vulvar pain and irritation are not only subject to physical pain, but emotional stress as well. Relationships are often strained as a result of intimacy issues since women will often abstain from sexual intercourse due to the pain it causes. Additionally, it is common for women to experience a decrease in their self-esteem. 

Although there are several products on the market that target vaginal dryness, one in particular helps to not only soothe, but also to restore vulvar skin. NeoGyn Vulvar Soothing Cream uses Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, to help comfort this delicate area and provide some relief for this common condition that is rarely discussed.

About Neogyn®:

Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and comfort the vulva. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.

RELATED LINKS
http://www.neogyn.us


'/>"/>
SOURCE NeoGyn
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bethesda Health Clinic Utilizes Donated MedInformatix EHR for Nine Years
2. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
3. Global Drug Stores and Health and Beauty Stores Market Size and Forecast to 2016
4. Omron Healthcare Announces New Over-The-Counter Electrotherapy Device
5. Health Diagnostic Laboratory, Inc. hosts Town Hall Meeting with Governor Tim Kaine and Senator Mark Warner
6. Beckers Hospital Review Names 100 Hospitals With Great Womens Health Programs
7. Donor Alliance Named Colorados Top Healthcare Company
8. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
9. One Of Colorados Largest Physician Networks Signs Agreement To Join Colorado Health Information Exchange
10. Verizon to Detail Health Care Fraud, Waste & Abuse - The Next Generation at National Association for Medicaid Program Integrity 2012 Conference, Sept. 18
11. Most Read Pharmaceutical and Health Condition News - August 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... -- It should come as no surprise to anyone that ... midst of a crippling opioid epidemic. According to the ... overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... from 2001 to 2015". During this time, the prescription rate ... drawing a compelling link between prescription and eventual addiction. The ...
(Date:7/12/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... to resolve pending patent litigation in the U.S. District Court ... regarding the Cialis ® (tadalafil) unit dose patent. This ... As part of the agreement, Cialis exclusivity is now expected ... "The unit dose patent for Cialis is valid and ...
(Date:7/11/2017)... July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing ... patients who suffer from painful intercourse and other painful pelvic pain conditions ... due to menopause. ... VuVatech LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a ...
Breaking Medicine Technology:
(Date:7/24/2017)... Kansas City, MO (PRWEB) , ... July 24, 2017 , ... ... for the acclaimed Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), part of ... an interim basis since 2016. , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... 24, 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, ... to and divided between two full-time university students enrolled in U.S. or Canadian ... To apply for the scholarship, students are asked to submit an essay between ...
(Date:7/24/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... to expand its solution to help government contractors more quickly and cost-effectively comply with ... address the authentication requirements within NIST SP800-171, but no matter how you address ...
(Date:7/24/2017)... ... ... that, although people are taking more steps to protect themselves from sunburn, half of all ... sunburn within the past year. It’s common and people have been dealing with them since ... people become conscientious of the risks that accompany sunburns. , The team at AloeVera.com ...
Breaking Medicine News(10 mins):